Peroxigard™ Canada efficacy against SARS-CoV-2, the virus which causes COVID-19 disease

Virox Technologies Press Release

Trusted in times of crisis, Peroxigard™, formulated with Accelerated Hydrogen Peroxide® is approved for use against SARS-CoV-2, the virus that causes COVID-19 when used in accordance with the directions for use against Poliovirus type 1.   For Peroxigard™ Concentrate use a 1:40 dilution and contact time 5 minutes and a contact time of 3 minutes for Peroxigard™ RTU and Wipes.

For further information, please review our formal press release below.

style=”border:0;”]